The polypharmacological effects of cannabidiol

J Castillo-Arellano, A Canseco-Alba, SJ Cutler, F León - Molecules, 2023 - mdpi.com
Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753).
This naturally occurring secondary metabolite does not induce intoxication or exhibit the …

Pharmacological properties, therapeutic potential, and legal status of Cannabis sativa L.: An overview

P Kumar, DK Mahato, M Kamle, R Borah… - Phytotherapy …, 2021 - Wiley Online Library
Marijuana, or Cannabis sativa L., is a common psychoactive plant used for both recreational
and medicinal purposes. In many countries, cannabis‐based medicines have been …

Cannabidiol and other non-psychoactive cannabinoids for prevention and treatment of gastrointestinal disorders: useful nutraceuticals?

V Martínez, A Iriondo De-Hond, F Borrelli… - International Journal of …, 2020 - mdpi.com
Cannabis sativa is an aromatic annual flowering plant with several botanical varieties, used
for different purposes, like the production of fibers, the production of oil from the seeds, and …

Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa

AR de Mello Schier… - CNS & Neurological …, 2014 - ingentaconnect.com
Anxiety and depression are pathologies that affect human beings in many aspects of life,
including social life, productivity and health. Cannabidiol (CBD) is a constituent non …

Effects of cannabidiol on exercise physiology and bioenergetics: a randomised controlled pilot trial

A Sahinovic, C Irwin, PT Doohan, RC Kevin… - Sports Medicine …, 2022 - Springer
Background Cannabidiol (CBD) has demonstrated anti-inflammatory, analgesic, anxiolytic
and neuroprotective effects that have the potential to benefit athletes. This pilot study …

PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In Vitro and In Ovo assessment

AI Fraguas-Sánchez, AI Torres-Suárez, M Cohen… - Pharmaceutics, 2020 - mdpi.com
The intraperitoneal administration of chemotherapeutics has emerged as a potential route in
ovarian cancer treatment. Nanoparticles as carriers for these agents could be interesting by …

Use of cannabidiol for the treatment of anxiety: a short synthesis of pre-clinical and clinical evidence

M Wright, P Di Ciano, B Brands - Cannabis and cannabinoid …, 2020 - liebertpub.com
Anxiety disorders have the highest lifetime prevalence of any mental illness worldwide,
leading to high societal costs and economic burden. Current pharmacotherapies for anxiety …

Cannabidiol and sports performance: a narrative review of relevant evidence and recommendations for future research

D McCartney, MJ Benson, B Desbrow, C Irwin… - Sports medicine …, 2020 - Springer
Cannabidiol (CBD) is a non-intoxicating cannabinoid derived from Cannabis sativa. CBD
initially drew scientific interest due to its anticonvulsant properties but increasing evidence of …

Differentiating cannabis products: drugs, food, and supplements

A Salehi, K Puchalski, Y Shokoohinia… - Frontiers in …, 2022 - frontiersin.org
“Hemp” refers to non-intoxicating, low delta-9 tetrahydrocannabinol (Δ9-THC) cultivars of
Cannabis sativa L.“Marijuana” refers to cultivars with high levels of Δ9-THC, the primary …

[HTML][HTML] Novel cannabinoid release system: encapsulation of a cannabidiol precursor into γ-cyclodextrin metal-organic frameworks

J Rodríguez-Martínez, MJ Sánchez-Martín… - Journal of Drug Delivery …, 2023 - Elsevier
Abstract γ-Cyclodextrin-metal-organic frameworks (γ-CD-MOFs) are developed as a new
promising and biocompatible material, which shows a great potential for drug delivery …